EUDA Health Holdings Limited (NASDAQ:EUDA) Short Interest Update
by Scott Moore · The Cerbat GemEUDA Health Holdings Limited (NASDAQ:EUDA – Get Free Report) saw a large decrease in short interest during the month of May. As of May 15th, there was short interest totaling 20,394 shares, a decrease of 76.6% from the April 30th total of 87,001 shares. Currently, 0.8% of the company’s shares are short sold. Based on an average trading volume of 53,985 shares, the days-to-cover ratio is currently 0.4 days.
Analyst Ratings Changes
A number of analysts recently issued reports on EUDA shares. Zacks Research raised EUDA Health from a “strong sell” rating to a “hold” rating in a research note on Friday, May 8th. Greenridge Global lowered their target price on EUDA Health from $120.00 to $55.00 and set a “buy” rating for the company in a research note on Monday, March 9th. Finally, Weiss Ratings cut EUDA Health from a “sell (d)” rating to a “sell (e+)” rating in a research note on Friday, May 8th. One research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, EUDA Health presently has a consensus rating of “Hold” and a consensus price target of $55.00.
View Our Latest Analysis on EUDA
EUDA Health Stock Down 3.8%
Shares of NASDAQ EUDA traded down $0.71 during trading hours on Friday, hitting $18.06. The company had a trading volume of 3,762 shares, compared to its average volume of 29,046. EUDA Health has a 1-year low of $5.26 and a 1-year high of $86.00. The firm’s 50 day moving average is $11.57 and its 200-day moving average is $27.61. The stock has a market capitalization of $54.00 million, a P/E ratio of -7.53 and a beta of 0.64.
EUDA Health (NASDAQ:EUDA – Get Free Report) last released its earnings results on Tuesday, May 5th. The company reported ($0.44) earnings per share for the quarter, beating the consensus estimate of ($1.20) by $0.76. The firm had revenue of $1.92 million during the quarter, compared to the consensus estimate of $3.90 million. On average, sell-side analysts predict that EUDA Health will post 1.6 earnings per share for the current year.
Hedge Funds Weigh In On EUDA Health
An institutional investor recently bought a new position in EUDA Health stock. Jane Street Group LLC bought a new stake in EUDA Health Holdings Limited (NASDAQ:EUDA – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 25,675 shares of the company’s stock, valued at approximately $59,000. Jane Street Group LLC owned approximately 0.07% of EUDA Health at the end of the most recent quarter. Institutional investors own 4.35% of the company’s stock.
EUDA Health Company Profile
EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.
EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.